Today, the VP & GC of Cambrex Corp (NYSE: CBM), Samantha Hanley, sold shares of CBM for $1.72M.
Following Samantha Hanley’s last CBM Sell transaction on June 12, 2017, the stock climbed by 4.5%. In addition to Samantha Hanley, 4 other CBM executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cambrex Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $152 million and quarterly net profit of $40.42 million. In comparison, last year the company earned revenue of $135 million and had a net profit of $25.03 million. CBM’s market cap is $2.07B and the company has a P/E ratio of 17.51. Currently, Cambrex Corp has an average volume of 316.7K.
In the last 30 days, insiders have sold $9.61M worth of CBM shares and purchased $3.3M worth of CBM shares. The insider sentiment on Cambrex Corp has been neutral according to 29 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.
